Demystifying Plexus: Insights From 4 Analyst Reviews
Portfolio Pulse from Benzinga Insights
Plexus (NASDAQ:PLXS) has received mixed ratings from 4 analysts in the past three months, with an average 12-month price target of $111.25, up from the previous $110.00. The company faces revenue challenges with a -8.89% decline as of September 30, 2023, but shows strong profitability with a net margin of 3.93% and effective use of equity with an ROE of 3.36%. Analysts' ratings range from 'Buy' to 'Neutral', with price target adjustments reflecting market dynamics and company performance.

January 18, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Plexus has received mixed analyst ratings with a slight increase in the average price target to $111.25. The company's financial performance shows both challenges in revenue growth and strengths in profitability and asset management.
The mixed analyst ratings and the slight increase in the average price target suggest a neutral short-term impact on PLXS stock price. The revenue decline may concern investors, but the strong profitability metrics could counterbalance negative sentiment. The high relevance is due to the direct mention of PLXS and detailed analyst ratings. The importance is significant as analyst ratings can influence investor perceptions, but not at the highest level due to the mixed nature of the ratings. The confidence level is high, given the clear data provided on analyst ratings and financial performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100